Skip to main content
Jun Chen, MD, Nephrology, Plano, TX

JunChenMD

Nephrology • Plano, TX

Physician

Join to view full profile

Dr. Chen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chen's full profile

Already have an account?

  • Office

    6300 W Parker Rd
    Ste 224
    Plano, TX 75093
    Phone+1 469-574-0464
    Fax+1 469-574-0471

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Nephrology, 2006 - 2008
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 2002 - 2005
  • Beijing Medical University
    Beijing Medical UniversityClass of 1992

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2005 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Loss of Function of NF1 Is a Mechanism of Acquired Resistance to Endocrine Therapy in Lobular Breast Cancer  
    A V Lee, Y X Feng, J Chung, S Ali, J Chen, J S Ross, Annals of Oncology
  • Tissue Plasminogen Activator Promotes White Matter Integrity and Functional Recovery in a Murine Model of Traumatic Brain Injury  
    Jun Chen, MD, Proceedings of the National Academy of Sciences

Press Mentions

  • Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV Infection
    Shanghai Public Health Clinical Center Completed Patient Enrollment in Clinical Study of PD-L1 Antibody ASC22 (Envafolimab) in Combination with Chidamide for Functional Cure of HIV InfectionSeptember 15th, 2022
  • Fast-Acting Immune Cells Provide Powerful Protection Against Stroke
    Fast-Acting Immune Cells Provide Powerful Protection Against StrokeAugust 1st, 2022
  • Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV Infection
    Shanghai Public Health Clinical Center Completed the First Patient Dosing in Clinical Study of PD-L1 Antibody ASC22 in Combination with Chidamide for Functional Cure of HIV InfectionJuly 3rd, 2022
  • Join now to see all

Grant Support

  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • BLRD Research Career Scientist Award ApplicationVETERANS HEALTH ADMINISTRATION2023–2030
  • A soft magnetoelastic microneedle patch for rapid skin cancer screeningUNIVERSITY OF CALIFORNIA LOS ANGELES2024–2029
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Vital capacity & airflow measurement for voice evaluation: A vortex whistle systemUNIVERSITY OF CENTRAL FLORIDA2023–2028
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Adiponectin on cerebrovascular regulation in vascular cognitive impairment and dementia (VCID)UNIVERSITY OF PITTSBURGH AT PITTSBURGH2022–2026
  • Adiponectin on cerebrovascular regulation in vascular cognitive impairment and dementia (VCID)UNIVERSITY OF PITTSBURGH AT PITTSBURGH2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Methods for microbiome compositional dataMAYO CLINIC ROCHESTER2022–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Novel molecular strategies to promote functional recovery after traumatic brain injuryVETERANS HEALTH ADMINISTRATION2016–2026
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Atherosclerosis assay development for drug efficacy and cytotoxicity screeningENDOMIMETICS, LLC2024–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Activation of the RXR/PPARγ axis improves long-term outcomes after ischemic stroke in aged miceVETERANS HEALTH ADMINISTRATION2022–2025
  • Nitric oxide releasing bionanomatrix to enhance dialysis fistula maturationENDOMIMETICS, LLC2016–2025

Dr. Jun Chen, Dr. Jun Chen, MD, Dr. J Chen